Real-time Estimate
Cboe BZX
12:41:38 2025-02-10 pm EST
|
5-day change
|
1st Jan Change
|
86.90 USD
|
-0.43%
|
|
-12.75%
|
-12.47%
|
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
- The company's MSCI ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- The company's attractive earnings multiples are brought to light by a P/E ratio at 12.45 for the current year.
- The company has a low valuation given the cash flows generated by its activity.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The company's enterprise value to sales, at 3.8 times its current sales, is high.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
4 months Revenue revision
1 months Revenue revision
Analysts' recommendations
12m Target Price Revision
Divergence of analysts' recommendations
Divergence of Target Price
Divergence of analysts' opinions
ESG: Ethical controversies
ESG: Human rights controversies
ESG: Tax subsidies controversies
|